Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Crohn's and Colitis Care is a specialized healthcare provider focused on the comprehensive management of patients with inflammatory bowel disease (IBD). The organization provides advanced clinical care, including the administration of biologic therapies and small molecule treatments for Crohn's disease and ulcerative colitis. By integrating specialized gastroenterology expertise with personalized treatment plans, the company aims to improve long-term outcomes and quality of life for patients suffering from chronic intestinal inflammation. Their services often include infusion therapy, nutritional counseling, and coordination of multidisciplinary care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Crohn's.